Isabelle C. Ree

Leiden, ZH 2300RC, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Long-term neurodevelopmental outcomes in infants with haemolytic disease of the newborn treated with darbepoetin.

Long-term neurodevelopmental outcomes in infants with haemolytic disease of the newborn treated with darbepoetin.

Journal: The Lancet. Haematology

Published: September 18, 2024

Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands: an open-label, single-centre, phase 2, randomised, controlled trial.

Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands: an open-label, single-centre, phase 2, randomised, controlled trial.

Journal: The Lancet. Haematology

Published: June 12, 2023

Neonatal sepsis in alloimmune hemolytic disease of the fetus and newborn: A retrospective cohort study of 260 neonates.

Neonatal sepsis in alloimmune hemolytic disease of the fetus and newborn: A retrospective cohort study of 260 neonates.

Journal: Transfusion

Published: August 02, 2022

Reply to Watchko and Maisels: Exchange transfusion in Rh haemolytic disease.

Reply to Watchko and Maisels: Exchange transfusion in Rh haemolytic disease.

Journal: Vox sanguinis

Published: May 19, 2021

Are fetal bilirubin levels associated with the need for neonatal exchange transfusions in hemolytic disease of the fetus and newborn?

Are fetal bilirubin levels associated with the need for neonatal exchange transfusions in hemolytic disease of the fetus and newborn?

Journal: American journal of obstetrics & gynecology MFM

Published: February 05, 2021

Exchange transfusions in severe Rh-mediated alloimmune haemolytic disease of the foetus and newborn: a 20-year overview on the incidence, associated risks and outcome.

Exchange transfusions in severe Rh-mediated alloimmune haemolytic disease of the foetus and newborn: a 20-year overview on the incidence, associated risks and outcome.

Journal: Vox sanguinis

Published: October 25, 2020

Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.

Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.

Journal: American journal of obstetrics and gynecology

Published: September 06, 2019

Necrotizing enterocolitis in haemolytic disease of the newborn: a retrospective cohort study.

Necrotizing enterocolitis in haemolytic disease of the newborn: a retrospective cohort study.

Journal: Vox sanguinis

Published: July 02, 2019

Updates in Neonatal Hematology: Causes, Risk Factors, and Management of Anemia and Thrombocytopenia.

Updates in Neonatal Hematology: Causes, Risk Factors, and Management of Anemia and Thrombocytopenia.

Journal: Hematology/oncology clinics of North America

Published: April 30, 2019

Predicting anaemia and transfusion dependency in severe alloimmune haemolytic disease of the fetus and newborn in the first 3 months after birth.

Predicting anaemia and transfusion dependency in severe alloimmune haemolytic disease of the fetus and newborn in the first 3 months after birth.

Journal: British journal of haematology

Published: January 08, 2019

Neonatal management and outcome in alloimmune hemolytic disease.

Neonatal management and outcome in alloimmune hemolytic disease.

Journal: Expert review of hematology

Published: May 16, 2017

Thrombocytopenia in neonatal sepsis: Incidence, severity and risk factors.

Thrombocytopenia in neonatal sepsis: Incidence, severity and risk factors.

Journal: PloS one

Published: December 14, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026